Comparison of the effects of vaginal estradiol and evening primrose pills in improving the visualization of the cervix during colposcopy

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2023
INTERVENTION: Intervention 1: Intervention group: Daily conjugated estrogen vaginal cream (one applicator) vaginally for 3 consecutive weeks. Intervention 2: Intervention group: Taking evening primrose tablets (manufactured by Iran's Barij Essential Oil Company) in a dose of 1000 mg vaginally for 3 consecutive weeks. CONDITION: Cesarean. ; Encounter for cesarean delivery without indication PRIMARY OUTCOME: Satisfactoryness of colposcopy. Timepoint: 4 weeks after the start of drug administration. Method of measurement: colposcopy. SECONDARY OUTCOME: Side effects such as stomach pain, breast pain, bloating, headache, itching, nausea and vomiting, diarrhea, chest or leg pain, impaired vision or speech, skin sensitivity, abnormal vaginal bleeding, vaginal itching and irritation. Timepoint: 4 weeks after the start of drug administration. Method of measurement: Ask the patient. INCLUSION CRITERIA: Women who are candidates for colposcopy and have an unsatisfactory colposcopy
Epistemonikos ID: f408ab0ab04559e1fcb28da75d454eaa1a5295ac
First added on: Feb 20, 2024